Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Recent findings demonstrate that among patients with small aortic annuli undergoing TAVR, those treated with self-expanding valves experienced significantly lower rates of bioprosthetic-valve dysfunction (9.4%) compared to those with balloon-expandable valves (41.6%), emphasizing the necessity for careful valve selection in clinical practice.
Cardiology April 19th 2024